Differentiating Psoriasis in Skin of Color


Joel M. Gelfand, MD, MSCE
Professor of Dermatology and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
Vice Chair of Clinical Research
Medical Director, Dermatology Clinical Studies Unit
Director, Psoriasis and Phototherapy Treatment Center
Joel M. Gelfand, MD, MSCE

Joel M. Gelfand MD MSCE is Professor of Dermatology and Epidemiology (with tenure) at the University of Pennsylvania’s Perelman School of Medicine. He is also Vice Chair of Clinical Research, Medical Director of the Dermatology Clinical Studies Unit, and Director of the Psoriasis and Phototherapy Treatment Center. He is a nationally and internationally recognized expert in psoriasis, clinical epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 200 scientific publications, editorials, reviews, and text book chapters (cited over 16,600 times, H index 57) which appear in journals such as JAMA, BMJ, European Heart Journal, Annals of Rheumatic Disease, JAMA Dermatology, JAAD, and the JID. He is the recipient of the American Skin Association’s Psoriasis Achievement Award, PENN’s Marjorie Bowman Award, Penn’s Department of Biostatistics and Epidemiology’s epidemiology teaching award, NPF’s inaugural award for scientific achievement, and is an elected member of the American Society for Clinical Investigation.

He has given over 10 named lectureships and keynote addresses including the Society for Investigative Dermatology’s Eugene M. Farber lecture and the American Academy of Dermatology’s Marion B. Sulzberger lecture. He has received grant support from NIH, FDA, PCORI, the Dermatology Foundation, the American Skin Association, the National Psoriasis Foundation, and numerous pharmaceutical companies to support his independent research program. The overarching goal of his research and clinical practice is to improve psoriasis patient outcomes in the skin and joints, while lowering the risk of diabetes, CV disease and mortality.

Statement of Need

Psoriasis (PsO) is a chronic, inflammatory skin disorder affecting about 1%-3% of the world’s population. There are many challenges in diagnosing and successfully managing individuals with PsO. For example, while there are similarities in PsO among ethnic groups, there are notable differences in presentation, quality of life, and treatment of PsO in people with skin of color.

The first episode of this four-episode CME Outfitters BriefCase learning series includes a video clinical encounter on differentiating PsO in people with skin of color, based on notable differences in disease presentation.

Learning Objectives

At the end of this CME/CE activity, participants should be able to improve diagnostic accuracy of psoriasis (PsO) in patients with skin of color, based on knowledge of notable difference in disease presentation.

The following learning objectives pertain only to those requesting CNE or CPE credit: Explain how to improve diagnostic accuracy of PsO in patients with skin of color, based on knowledge of notable differences in disease presentation.

Financial Support

Supported by educational grants from Celgene and Novartis Pharmaceuticals Corporation.

Target Audience

Dermatologists, primary care physicians, nurse practitioners, physician assistants, and pharmacists.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit  from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
UAN: 0376-0000-21-062-H02-P

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Gelfand reports that he receives grants from AbbVie Inc.; Boehringer Ingelheim; Celgene Corporation; Janssen Biologics, Inc.; Novartis Corporation; Ortho Dermatologics; and Pfizer Inc. He is a consultant for Boehringer Ingelheim; Bristol-Myers Squibb Company; Janssen Biologics, Inc.; NeuroDerm Data and Safety Monitoring Board (DSMB); Novartis Corporation; Pfizer Inc.; Sun Pharmaceutical Industries; and UCB Data and Safety Monitoring Board (DSMB). He receives other financial or material support as a co-patent holder of resiquimod for treatment of cutaneous T-cell lymphoma; and as Deputy Editor for the Journal of Investigative Dermatology, receiving honoraria from the Society for Investigative Dermatology.

Dr. Helfand (peer reviewer) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

  • Mae Ochoa, RPh (peer reviewer)
  • Poshala Tish Aluwihare, PhD (planning committee)
  • Susan Perry (planning committee)
  • Jan Perez (planning committee)
  • Sharon Tordoff (planning committee)

CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.


Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).


Differentiating Psoriasis in Skin of Color
Event Date: 06/18/2020